This record was last updated June 15, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-center, non-interventional and prospective study of patients receiving Epidyolex as part of standard clinical practice in France. The study will state an overview of patient characteristics and clinical history (including age, sex, diagnosis, duration of epilepsy, predominant seizure type, previous medications, current co-medications and Epidyolex dose), and an evaluation of retention rates, safety profile, seizure activity, changes in executive function and quality of life measured in a 2-year follow-up period.
Protocol Amendment History
7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-03-06; most recent amendment 2026-06-11.
Status change: Completed → Active, Not Recruiting2025-04-10
Status change: Recruiting → Completed2024-08-14
Status change: Not Yet Recruiting → Recruiting2023-05-15